Skip to main content

John M. Leonard, M.D.

Equibles does not estimate personal net worth.

Get an email with a short summary when Intellia Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get NTLA alerts

About John M. Leonard, M.D.

John M. Leonard, M.D. is recorded as Board Member at Intellia Therapeutics, Inc. (NTLA) since June 11, 2025. The proxy statement of Intellia Therapeutics, Inc. reports total compensation of $5,063,899 for John M. Leonard, M.D. in fiscal 2025, including a base salary of $708,000. Disclosed compensation is on record for 9 fiscal years. Intellia Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Intellia Therapeutics, Inc. includes Edward J. Dulac III (CFO), Andrew D. Schiermeier (COO), James Basta (General Counsel) and 7 others.

Affiliation history

Company network

Leadership on record at Intellia Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Intellia Therapeutics, Inc. (NTLA) $708,000 $5,063,899
2024 Intellia Therapeutics, Inc. (NTLA) $687,000 $15,330,547
2023 Intellia Therapeutics, Inc. (NTLA) $660,000 $11,657,262
2022 Intellia Therapeutics, Inc. (NTLA) $630,000 $10,096,590
2021 Intellia Therapeutics, Inc. (NTLA) $600,000 $9,773,560
2020 Intellia Therapeutics, Inc. (NTLA) $580,000 $3,635,676
2019 Intellia Therapeutics, Inc. (NTLA) $559,200 $903,786
2018 Intellia Therapeutics, Inc. (NTLA) $550,000 $9,708,330
2017 Intellia Therapeutics, Inc. (NTLA) $395,833 $2,592,874

Recent activity

No call appearances or filed executive changes recorded yet.